Beneficial Effects of High-Density Lipoproteins on Acquired von Willebrand Syndrome in Aortic Valve Stenosis.

@article{Gebhard2018BeneficialEO,
  title={Beneficial Effects of High-Density Lipoproteins on Acquired von Willebrand Syndrome in Aortic Valve Stenosis.},
  author={Catherine Gebhard and Foued Maafi and Barbara E. St{\"a}hli and Arnaud Bonnefoy and Walid Nachar and Adriana Benjamim de Oliveira Moraes and M{\'e}lanie R. Mecteau and T{\'e}odora Mihalache-Avram and V{\'e}ronique Lavoie and A. E. Kernaleguen and Yanfen Shi and David Busseuil and Malorie Chabot-Blanchet and Louis P Perrault and David Rhainds and {\'E}ric Rh{\'e}aume and J C Tardif},
  journal={Thrombosis and haemostasis},
  year={2018},
  volume={118 2},
  pages={288-297}
}
BACKGROUND  Infusions of apolipoprotein A-I (apoA-I), the major protein component of high-density lipoproteins (HDL), result in aortic valve stenosis (AVS) regression in experimental models. Severe AVS can be complicated by acquired von Willebrand syndrome, a haemorrhagic disorder associated with loss of high-molecular-weight von Willebrand factor (vWF… CONTINUE READING